0.56 USD
▼+0.04-5.87%
2026-08-03
市值
$23.07M
市盈率
—
EPS
-1.29
股息率
—
52 周区间
0.51 – 1.83
成交量
83.75K
Beta
-0.40
目标价
5.50
52W 低 0.5152W 高 1.83
价格走势
公司简介
Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom. The company develops VTP-1000, an antigen-specific immune tolerance candidate, which is in Phase I clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease; and VTP-300, an immunotherapy, which is in Phase II clinical trial for the treatment of chronic hepatitis B virus infection. It has a license agreement with...